HEALTH
Adjuvant alectinib improves disease-free survival in lung cancer
![Adjuvant alectinib improves disease-free survival in lung cancer](https://connecticutnewspress.com/wp-content/uploads/2024/04/5879-adjuvant-alectinib-improves-disease-free-survival-in-lung-cancer.jpg)
Adjuvant alectinib improves disease-free survival compared with platinum-based chemotherapy among patients with resected ALK-positive non-small cell lung cancer (NSCLC), according to a study published in the April 11 issue of the New England Journal of Medicine…